Real-World Prevalence of PD-L1 Expression in Chinese Patients with Advanced or Metastatic NSCLC: Express II Study

被引:0
作者
Lin, D. [1 ]
Yang, X. [1 ]
Jiang, L. [2 ]
Wang, W. [2 ]
Hou, Y. [3 ]
Li, Y. [4 ]
Jin, Y. [4 ]
Fan, X. [5 ]
Sun, W. [6 ]
Yun, J. [7 ]
Li, P. [7 ]
Kuang, D. [8 ]
Zhang, L. [9 ]
Ni, J. [10 ]
Mao, A. [11 ]
Tang, W. [11 ]
Liu, Z. [11 ]
Wang, J. [11 ]
Xiao, S. [11 ]
机构
[1] Beijing Canc Hosp, Beijing, Peoples R China
[2] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
[4] Fudan Univ, Shanghai Med Coll, Dept Pathol, Shanghai, Peoples R China
[5] Nanjing Drum Tower Hosp, Nanjing, Peoples R China
[6] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[7] Sun Yat Sen, Canc Hosp, Guangzhou, Peoples R China
[8] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Shanghai, Peoples R China
[9] Shanghai Pulm Hosp, Shanghai, Peoples R China
[10] First Hosp Jilin Univ, Eastern Div, Changchun, Peoples R China
[11] Bldg A,Headquarters Pk Phase 2,1582 Gumei Rd, Shanghai, Peoples R China
关键词
Non-small cell lung cancer; programmed death-ligand 1; IHC;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P33.12
引用
收藏
页码:S410 / S410
页数:1
相关论文
empty
未找到相关数据